About
Mr. Donohue has served as a director of Acurx since July 2021. Since April 2004 he has been a Vice President with Charles River Associates (Nasdaq: CRAI), a global economic, financial and management consulting firm, and he has more than 30 years of experience in valuation, damages and forensic accounting. He is a Certified Public Accountant in Maryland, a Certified Valuation Analyst and Accredited in Business Valuation, and holds a B.S. in Accountancy from Villanova University.
Roles
Acurx Pharmaceuticals, Inc.
Director · Current role
July 2021–present
Charles River Associates (CRAI)
Vice President
2004 - present
Director Compensation
FY 2024Fees earned or paid in cash
$55,000
ComponentAnnual cash retainers and committee/leadership fees earned in 2024
Option awards
$22,104
ComponentStock options granted during 2024, ASC 718 grant-date fair value
Total
$77,104
Also at Acurx Pharmaceuticals, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.